BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
Most protocols last 48 weeks, followed by a rest period
Compatible with Luer Tip (LT) and Luer Lock (TLL) syringes
L-Glutathione reduced Based on 56 publication(s) in Google Scholar L-Glutathione reduced (GSH
Moreover, UV filters have been identified in diurnal animal lenses
54 Additionally, metabolic syndrome is a risk factor for chronic kidney disease (CKD) that is at least in part independent of diabetes and hypertension and probably mediated by ROS